The Emergency in India in 1975 led to severe film censorship, impacting movies like Aandhi and Kissa Kursi Ka, which had to ...
This significant fundraising initiative aims to support its Rs 13,630 crore acquisition of Bharat Serums and Vaccines Ltd (BSV), a transaction announced in late July, as reported by The Economic Times ...
Vande Bharat sleeper train: Railway Minister Ashwini Vaishnaw on Sunday unveiled the prototype of the Vande Bharat sleeper coach at the Bharat Earth Movers Limited (BEML) facility in Karnataka's ...
Sharing glimpses of jiu-jitsu (a form martial arts) from his Bharat Jodo Nyay Yatra, Leader of Opposition in Lok Sabha Rahul Gandhi Thursday hinted that there might be a ‘Bharat Dojo Yatra’ soon. Dojo ...
UPI Circle and Bharat BillPay for Business (BBPS) are the new two offerings. While the former allows UPI users to delegate payments either in full or partial to trusted secondary users ...
Defence stocks saw a 20-25 percent decline after a strong rally over the past year. The government, aiming at indigenous manufacturing and self-sufficiency, has been bolstering the defence sector ...
(Reuters) New Delhi: Hyderabad-based Bharat Biotech Ltd on Monday launched oral cholera vaccine (OCV) Hillchol, made in collaboration with Hilleman Laboratories, the University of Gothenburg and ...
Bharat Biotech unveiled Hillchol, a new single-strain oral cholera vaccine, developed with Hilleman Laboratories. Addressing the high global demand for cholera vaccines, the company can produce up to ...
In an X post, Bengaluru Central MP PC Mohan wrote, “India's first Vande Bharat sleeper train is set to be dispatched from Bengaluru's BEML plant by September 20 and is expected to be operational ...
Vaccine maker Bharat Biotech International Ltd on Tuesday (August 27, 2024) launched Hillchol (BBV131), a novel single-strain oral cholera vaccine (OCV) it has developed under licence from ...
HYDERABAD, Aug 27 (Reuters) - India's Bharat Biotech said on Tuesday its oral cholera vaccine cleared a late-stage trial and that it plans a global launch, aiming to make up to 200 million doses a ...